UMIN ID: UMIN000006194
Registered date:01/12/2011
"Adjuvant Chemotherapy Trial of S-1 for breast cancer with ER-positive and HER2-negative" Pharmacodynamics, Pharmacokinetics and Pharmacogenomics study
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Female patient with invasive breast cancer |
Date of first enrollment | 2011/09/06 |
Target sample size | 1400 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Blood and urine collection for pharmacokinetics analysis |
Outcome(s)
Primary Outcome | Pharmacokinetics of S-1 |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 75years-old |
Gender | Female |
Include criteria | |
Exclude criteria | None |
Related Information
Primary Sponsor | Graduate School of Medicine Kyoto University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | None |
Secondary ID(s) | G-431 |
Contact
public contact | |
Name | Hiroshi Ishiguro |
Address | 54 Shogoinkawahara-machi, Sakyo-ku, Kyoto-city Japan |
Telephone | 075-751-4950 |
hkkishi@kuhp.kyoto-u.ac.jp | |
Affiliation | Graduate School of Medicine Kyoto University Department of Target Therapy Oncology |
scientific contact | |
Name | Hiroshi Ishiguro |
Address | 54 Shogoinkawahara-machi, Sakyo-ku, Kyoto-city Japan |
Telephone | 075-751-4950 |
hkkishi@kuhp.kyoto-u.ac.jp | |
Affiliation | Graduate School of Medicine Kyoto University Department of Target Therapy Oncology |